The company has prov¥♠•incial-level research and developme <nt platforms such as the "Ji±←angsu Animal Disease Prevention and Control Bi♣&oengineering Technology Research Cenδ∏✘ ter", "Jiangs÷↑u Province Certified Enterprise Technologyσ♥ ± Center", "Jiang$₩$<su Province Postdoctoral Innovation Practi →αce Base", and "Jiangsu Pr₹§€ovince Graduate Workstation", as well as m¥> unicipal level research and development plat¶ forms such as the "Wuxi Academician W✘ ∞ orkstation" and "Jiangyi♦₹n Academician Workstation". The company has ∑α≥'established long-term and‍≥∏ stable industry university research cooper≠₽ation relationships with well-known domest↑•ic research institutes suc嶧h as the School of Veterinary Medici✔€ne at Nanjing Agricultural University,  ₩₽Jiangnan University,↑¥ the School of Veterinary Medicine at Yangzhou U♥>±Ωniversity, Jiangsu Academy of Agricult♣←₩ural Sciences, and Harbin Veterinary Researc&Ω♠εh Institute. In recent years, we have undertaken ≥±more than 20 projects fr φom national, provincial, and municipal sc$•₹©ience and technology departme₽​π nts, obtained 15 inventi☆≥≠∏on patents, and obtained 15 national new ≈Ω₽veterinary drug certificates.

By 2023, the company will be the <☆©only biopharmaceutical enterprise in Wuxi speci→λ αalizing in the production of livestock and poultr≠∏y vaccines, and also the largest hi>₹gh-tech private enterprise in Jiangsu Provγ←ince specializing in♦♠ the production of livestock and pouα¥✔ltry vaccines; With the deepeningβδ'₩ of the company's technological inno÷ ₽vation work item by item, the company has formed☆  a mature research a ₽nd innovation system that integra↔$γtes industry univers→®ity research cooperation. With the support of the™' company's strong technical team, it cont≥¥δσinuously strengthens cooperation ¥✘‍Ωwith well-known domestic reseδ₹δarch institutions, industry university research ‍‌✘cooperation, and scientific rese↑♦β"arch cooperation with similar enterprises t≤ "o jointly develop livestock an₽₩d poultry vaccine related technologies. It clo•εsely combines with the forefront of breedi∑₹ng and adopts the latest technolog₹​ ies such as reverse genetics a↕Ωnd gene recombination to conduct new produc₽δβεt research and developm✘ε£ent, improve market c♣∞¥♦ompetitiveness, and currently ranks among the £≤∞λtop fifteen in the industry in annual sales; ¶∑¥The pig ring vaccine series products have m ≈≥aintained a leading market™&↑ share in the country for'₹Ω 15 consecutive years, with t$↕he market share of recombinant Ne☆​≠¥wcastle disease virus inactiv •∏ated vaccines continuing to le δ∏ad. The market share of swine ✔≥∏fever live vaccines and pseudo ¥¥αrabies live vaccines ranks§↕ among the top in the industry; R'≠®esearch and innovation capabilities‍δ¶ , with annual rankings of the top ten scienti♠±‍fic research achievements and technolo$λgical levels in the industry; The h€λ©'igh-end market share of large-sc★ε™ale aquaculture group≥βs exceeds that of imported vaccines.